Cutaneous drug-induced lupus erythematosus: Clinical and immunological characteristics and update on new associated drugs
Pauline Bataille(Sorbonne Université), Patricia Senet(Sorbonne Université), François Chasset(Sorbonne Université), A. Soria(Inserm), A. Barbaud(Centre Hospitalier Régional et Universitaire de Nancy), J.‐B. Monfort(Sorbonne Université), T. De Risi-Pugliese(Sorbonne Université), C. Françès(Navarre Institute of Health Research)
Cited by 28
Related Papers
Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*
|British Journal of Dermatology|2021|414
European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
|Journal of the European Academy of Dermatology and Venereology|2017|262
Skin Thickness Changes in Normal Aging Skin
|Gerontology|2009|258
Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey
|Blood|2012|241
Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients
|Annals of the Rheumatic Diseases|2007|235